Clinical Trial Update: Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Lutathera for inoperable, progressive meningioma after external beam radiation therapy, currently recruiting. The study a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Mayo Clinic | Conditions: Grade 1 Meningioma, Grade 2 Meningioma | Phase 2 | Status: RECRUITING